Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | -136,7x - -151,1x | -143,9x |
| Selected Fwd EBIT Multiple | 59,5x - 65,8x | 62,6x |
| Fair Value | ₺3,19 - ₺5,19 | ₺4,19 |
| Upside | -63,4% - -40,5% | -51,9% |
| Benchmarks | Ticker | Full Ticker |
| Aksa Enerji Üretim A.S. | AKSEN | IBSE:AKSEN |
| Consus Enerji Isletmeciligi ve Hizmetleri A.S. | CONSE | IBSE:CONSE |
| Akfen Yenilenebilir Enerji | AKFYE | IBSE:AKFYE |
| Biotrend Cevre ve Enerji Yatirimlari A.S. | BIOEN | IBSE:BIOEN |
| Galata Wind Enerji A.S. | GWIND | IBSE:GWIND |
| Mogan Enerji Yatirim Holding Anonim Sirketi | MOGAN | IBSE:MOGAN |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| AKSEN | CONSE | AKFYE | BIOEN | GWIND | MOGAN | ||
| IBSE:AKSEN | IBSE:CONSE | IBSE:AKFYE | IBSE:BIOEN | IBSE:GWIND | IBSE:MOGAN | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 40.7% | NM- | 48.2% | NM- | 44.2% | NM- | |
| 3Y CAGR | 41.4% | -17.4% | 38.6% | NM- | 40.8% | NM- | |
| Latest Twelve Months | -43.2% | 116.8% | -41.3% | -715.2% | -32.4% | -112.5% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 15.2% | -3.3% | 28.2% | 10.7% | 61.9% | 12.5% | |
| Prior Fiscal Year | 18.5% | -20.0% | 47.0% | 1.9% | 55.0% | 14.7% | |
| Latest Fiscal Year | 16.9% | 4.2% | 34.1% | -13.7% | 42.2% | -2.6% | |
| Latest Twelve Months | 16.9% | 4.2% | 34.1% | -13.7% | 42.2% | -2.6% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 2.34x | 2.90x | 5.22x | 4.71x | 6.22x | 4.63x | |
| EV / LTM EBITDA | 10.1x | 12.0x | 9.3x | 50.3x | 9.1x | 8.4x | |
| EV / LTM EBIT | 13.9x | 69.3x | 15.3x | -34.5x | 14.7x | -176.7x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -34.5x | 14.7x | 69.3x | ||||
| Historical EV / LTM EBIT | -176.7x | -176.7x | -176.7x | ||||
| Selected EV / LTM EBIT | -136.7x | -143.9x | -151.1x | ||||
| (x) LTM EBIT | (338) | (338) | (338) | ||||
| (=) Implied Enterprise Value | 46,168 | 48,598 | 51,028 | ||||
| (-) Non-shareholder Claims * | (38,374) | (38,374) | (38,374) | ||||
| (=) Equity Value | 7,794 | 10,224 | 12,654 | ||||
| (/) Shares Outstanding | 2,440.1 | 2,440.1 | 2,440.1 | ||||
| Implied Value Range | 3.19 | 4.19 | 5.19 | ||||
| FX Rate: TRY/TRY | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 3.19 | 4.19 | 5.19 | 8.72 | |||
| Upside / (Downside) | -63.4% | -51.9% | -40.5% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | AKSEN | CONSE | AKFYE | BIOEN | GWIND | MOGAN | |
| Enterprise Value | 74,108 | 3,965 | 26,618 | 12,670 | 14,617 | 59,652 | |
| (+) Cash & Short Term Investments | 1,057 | 27 | 1,159 | 99 | 1,318 | 3,009 | |
| (+) Investments & Other | 6 | 0 | 1 | 319 | 94 | 0 | |
| (-) Debt | (28,167) | (1,979) | (8,085) | (3,953) | (2,292) | (32,143) | |
| (-) Other Liabilities | (3,886) | 0 | (99) | (10) | 0 | (9,240) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 43,118 | 2,012 | 19,594 | 9,125 | 13,738 | 21,278 | |
| (/) Shares Outstanding | 1,226.3 | 771.0 | 1,197.0 | 500.0 | 540.0 | 2,440.1 | |
| Implied Stock Price | 35.16 | 2.61 | 16.37 | 18.25 | 25.44 | 8.72 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 35.16 | 2.61 | 16.37 | 18.25 | 25.44 | 8.72 | |
| Trading Currency | TRY | TRY | TRY | TRY | TRY | TRY | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |